TAYLA Laverty, from Prospect in Tasmania, stared down the barrel of a one-in-100 chance of becoming an instant millionaire last weekend, thanks to the nationwide Maxigesic 'Chance to win $1 million' promotion.
The promotion was open to Australian residents over the age of 18 and attracted entries from across the entire country, with 10 finalists drawn at random from 27,000 entries nationwide.
While no-one picked up the $1m envelope out of the 100 possible, the other nine finalists picked up a cool $5,000 runners' up prize, but Laverty's was a $20,000 envelope.
CEO of AFT Pharmaceuticals and inventor of Maxigesic (ibuprofen paracetamol combination), Dr Hartley Atkinson, said he was thrilled with the response to the competition.
"I developed Maxigesic as an alternative to other analgesics, particularly those containing codeine, which has been shown to be addictive, and not especially effective in low doses," explained Atkinson.
"Maxigesic, on the other hand, is non-habit-forming, and has been clinically proven to be an effective pain reliever," he claimed.
Pictured are Hartley Atkinson with winner Tayla Laverty.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Sep 17
